The research tackles whether LLMs can serve as useful tools in pharmacometrics without undermining the integrity of mechanistic, domain-specific models. The analysis shows that while LLMs are unlikely ...

Five months after Databricks Inc. acquired one of its main rivals for $1 billion, Supabase has raised $100 million in ...